News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

September 2014

Top

MedGenesis and Pfizer partner for Parkinson's disease treatments
17 September 2014 US-based Pfizer has collaborated with Canada-based MedGenesis Therapeutixon on potential treatments for Parkinson's...

Warwick researchers discover new drug target to prevent postpartum haemorrhage
17 September 2014 Researchers at the University of Warwick in UK have discovered a new drug target, Kir7.1, for postpartum haemorrhage (PPH) in...

GSK seeks commercial licence from Five Prime for muscle disease treatment
16 September 2014 GlaxoSmithKline (GSK) has acquired a commercial licence from Five Prime Therapeutics by exercising an option for products to treat undisclosed muscle disease....

Gilead signs licensing agreements with seven Indian firms for hepatitis C treatments
16 September 2014 US-based Gilead Sciences has signed non-exclusive licensing agreements with seven India-based generic pharmaceutical firms to expand the availability of its chronic hepatitis C medicines in...

FDA approves Hyqvia to treat primary immunodeficiency
15 September 2014 Baxter and Halozyme have received approval from the US Food and Drug Administration (FDA) for Hyqvia to treat adult patients with primary immunodeficiency...

Animal trials misguide drug discovery and development, says PharmaInformatic
15 September 2014 Research by Germany-based biotech company PharmaInformatic compared study results on drug-uptake (oral bioavailability) in animals and humans for a wide range of approved and established drugs...

Takeda and Orexigen receive FDA approval for new weight-loss pill
12 September 2014 Takeda Pharmaceuticals USA and Orexigen Therapeutics have received approval from the US Food and Drug Administration (FDA) for a new weight-loss pill called Contrave (naltrexone HCI and...

Mylan to acquire US rights of Arixtra for $225m
12 September 2014 Mylan Ireland has signed an agreement to acquire the US commercialisation, marketing and intellectual property rights of Arixtra (fondaparinux sodium) Injection and the authorised generic (AG)...

Genmab and Seattle Genetics establish new antibody-drug conjugate collaboration
11 September 2014 Danish biotechnology company Genmab has entered into an additional antibody-drug conjugate (ADC) collaboration with US-based Seattle Genetics....

Ebola outbreak endangers national existence of Liberia, says minister
11 September 2014 Liberia's Defence Minister Brownie Samukai has said that the Ebola virus disease outbreak is seriously threatening the country's future....

GSK partners with UK and South African research councils for NCDs in Africa
10 September 2014 British drug-maker GlaxoSmithKline (GSK) has partnered with UK and South African medical research councils (MRC) to carry out research on non-communicable diseases (NCDs) in Africa....

Cipla and S&D Pharma partner for business in Czech Republic and Slovakia
10 September 2014 India-based Cipla has partnered with UK's S&D Pharma to launch affordable, high-quality alternatives in the Czech Republic and Slovakia....

University of Toronto partners with Janssen and J&J on brain treatments
09 September 2014 The University of Toronto has partnered with Janssen and Johnson & Johnson (J&J) Innovation Center of California to identify and validate new therapeutic targets that could treat major...

FDA grants approval for Keryx’s ferric citrate to treat dialysis patients with hyperphosphatemia
09 September 2014 Keryx Biopharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its ferric citrate (formerly known as Zerenex), a new oral iron-based treatment for...

Merck’s Keytruda receives FDA approval to treat melanoma
08 September 2014 Merck has received approval from the US Food and Drug Administration (FDA) for its Keytruda (pembrolizumab) at a dose of 2mg/kg every three weeks to treat patients with unresectable or...

Takeda seeks approval of Leuplin for hormone-dependent diseases in Japan
08 September 2014 Takeda Pharmaceutical is seeking approval from the Japanese Ministry of Health Labour and Welfare for its Leuplin six month depot (leuprorelin acetate) to treat prostate and premenopausal...

Bayer seeks marketing authorisation of aflibercept solution for injection in Japan
05 September 2014 Bayer Yakuhin has tendered a new application for marketing authorisation for its aflibercept solution for injection into the eye in...

Infinity and AbbVie partner to develop and commercialise duvelisib for cancer
05 September 2014 Infinity Pharmaceuticals has partnered with AbbVie to develop and commercialise its duvelisib (IPI-145), an oral inhibitor of phosphoinositide-3-kinase (PI3K) delta and PI3K-gamma, to...

Intrexon and Sanofi partner for production of specific family of APIs
04 September 2014 US-based biotech firm Intrexon has partnered with Sanofi Chimie to develop an effective production process for a specific family of its marketed active pharmaceutical ingredients (APIs)....

ViiV Healthcare’s Triumeq for HIV treatment receives EU marketing authorisation
04 September 2014 GlaxoSmithKline's ViiV Healthcare has received marketing authorisation from the European Commission (EC) for its Triumeq (dolutegravir 50mg/abacavir 600mg/lamivudine 300mg) tablets to treat HIV...

Japanese researchers develop new 30-minute method to detect Ebola virus
03 September 2014 Researchers from the Nagasaki University in Japan have developed a new method to detect the presence of Ebola virus in 30 minutes....